India to add more AIDS, TB drugs in essential medicines list: Sources MUMBAI: India is likely to add more HIV/AIDS and tuberculosis drugs to its list of essential medicines that are subject to price caps, people directly involved in the process said, in a move to improve affordability of drugs to treat the deadly diseases. All the drugs on the ... Read More »
12 of top 25 pharma shares rally over 100% in FY15 Fiscal 2014-15 (FY15) has turned out to be a good year for pharmaceutical companies with nearly half of the top 25 pharma stocks becoming multi-baggers during the year. As many as 12 out of top 25 most valued pharmaceutical firms have seen price appreciation of more than 100% during ... Read More »
Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group Novartis announced today that it is stepping up its efforts to harness the body’s immune system to combat cancer. The company has entered into a major multiyear alliance with Aduro Biotech that is focused on the discovery and development of next generation cancer immunotherapies ... Read More »
US FDA approves Semler Scientific’s next generation PAD testing system The US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for Semler Scientific’s next generation peripheral artery disease (PAD) testing system. The next generation system features convenience and ease of use characteristics along with compatibility to electronic medical record systems for easy accessibility of data. The system was ... Read More »
GSK becomes partner in new global fund to accelerate dementia research GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new global fund for dementia research. The Dementia Discovery Fund, which is being established by the UK government with initial commitments totalling $100m, brings together leading pharmaceutical companies, the UK ... Read More »
Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics NEW DELHI: Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics, taking its holding in the company to 100 per cent. Lupin had earlier acquired ... Read More »
Sun Pharma readies new leadership team Taking forward its acquisition of Ranbaxy Laboratories , Sun Pharma has put in place a team of top executives, including Dilip Shanghvi’s son Aalok Shanghvi, to lead the businesses of both the organisations. While the leadership team is comprised mainly from the representatives of Sun Pharma, it also has executives from Ranbaxy, drawing upon ... Read More »
Suven Life Sciences gets patents for neuro-degenerative drug Pharmaceutical firm Suven Life SciencesBSE 0.45 % has been granted a patent each by Eurasia and Israel for drug used in the treatment of neuro-degenerative diseases. Neuro-degenerative ailments include Alzheimer’s disease, Schizophrenia and Parkinson’s disease. In a BSE filing, the company said it has received “grant of one product patent from Eurasia ... Read More »
Sun Pharma, SPARC hit new high on USFDA nod for ELEPSIA XR Shares of Sun Pharmaceutical Industries and Sun PharmaAdvanced Research Company (SPARC) have touched their respective record high after SPARC announced that the U.S. Food and Drug Administration (FDA) have approved its new drug application (NDA) for ELEPSIA XR (Levetiracetam extended-release tablets 1000 mg and 1500 mg). The product ... Read More »
VIVAN Life Sciences Blog